intelligence

5 Comments

    • ON: Tue Sep 23rd 09:31 AM
      Commented on:
      China Pharma Reports Improved Collection of Accounts Receivable
      for some reason every time you report an article on this Company, it sounds positive but has a negative conclusion ---the positive cash flow is great AND THE COMPANY ONLY NEEDS A $2 STOCK FOR LISTING ON THE AMEX--SHOULD BE ATTAINABE WHEN THIRD QUARTER RESULTS ARE PUBLISHED
      View article »
    • ON: Fri Jun 27th 07:25 AM
      Commented on:
      China 3C Group Hits Major Milestone
      the Company had $25 million of cash at Dec 30, 2007 and if it earns 45 cents this year, will have close to $1 per share by year end. With no debt, the Company will be selling for 1 times earnings net of cash
      View article »
    • ON: Mon Jun 9th 11:24 AM
      Commented on:
      China Biotech Week in Review: Earnings, Deals and Drug Development
      Sales increased by 62%--naturally receivables increased

      bad debts went down--read the press release
      View article »
    • ON: Mon May 5th 10:45 AM
      Commented on:
      Biotech in Review: Investment Capital for China Biopharma
      here you go again missing the good news on china pharma receivables
      1. reduced old receivables by more than 50%
      2. sales up 60% while receivables up ONLY half that amount
      3. bad debts not as bad as reservesd for originally

      all good news--and WHY IS THIS A BIOTECH STOCK-NEXT MAYBE INCLUDED IN JUST TECH
      View article »
    • ON: Thu May 1st 08:03 AM
      Commented on:
      China Pharma's Q1 Impressive, But Collection Problems Are Worrisome
      ACCOUNTS RECEIVABLE UP ONLY 32% VERSUS SALES UP 62%-A VERY GOOD SIGN--AVERAGE DAYS OUTSTANDING FOR ACCOUNTS RECEIVABLE IS DOWN--A GOOD SIGN--DO THE MATH--SAME IS TRUE FOR BAD DEBTS--DOWN AS A % OF SALES
      View article »
Loading...
Symbols:
Authors:
Quick Links:
Contribute an Article Become a Seeking Alpha Contributor

Transcripts

More Transcripts»